Corbevax Covid-19 vaccine recommended for emergency use in 12-18 years age group - The Drugs Controller General Of India (DCGI) has already approved Corbevax for restricted use in emergency situation in adults on December 28.
NITI Aayog member (Health) V K Paul at a press conference recently said that the additional need for vaccination and inclusion of population for vaccination is examined constantly.
An expert panel of India’s central drug authority on Monday recommended granting restricted emergency use authorisation to Biological E’s Covid-19 vaccine, Corbevax, for ages 12 to 18 years subject to certain conditions, official sources said.
Biological-E, Corbevax, COVID-19, Vaccination, covid, vaccine, vaccine for children, DCGI, Drugs Controller General of India, Subject Expert Committee, SEC